跳至主要内容
临床试验/NCT04627623
NCT04627623Unknown不适用

Prevalence and Risk Factors of COVID-19 Infection in the Upper Silesian Agglomeration Population in 2020

Medical University of Silesia1 个研究点 分布在 1 个国家目标入组 6,000 人开始时间: 2020年6月22日最近更新:
适应症

试验速览

阶段
不适用
入组人数
6,000
试验地点
1
主要终点
Estimation of prevalence of specific anti-SARS-CoV-2 IgM and IgG antibodies in general population.

研究概览

简要总结

Project is designed as a comprehensive population-based epidemiological study in Upper-Silesian Conurbation (Poland) aiming at:

  1. analysis of available data on incidence and mortality due to COVID-19 and
  2. estimation of the occurrence of viral infection SARS-CoV-2 as revealed by the results of serological test (ELISA: IgM, IgG), with assessment of risk factors.

The project's objectives are: to assess incidence and mortality due COVID-19 according to sex, age and coexisting diseases; to determine the level of potential "underdiagnosis" of the magnitude of COVID-19 mortality using vital statistics data for Upper-Silesian Conurbation; to assess the prevalence of SARS-CoV-2 based on the level of seropositivity in Upper-Silesian Conurbation; to identify host-related and environmental risk factors if the infection. Analysis of existing data will include monthly records on incidence and mortality over the period 01.01.2020-31.12.2020 and comparison of the findings with the monthly records of 2018 and 2019, for the same population. Cross-sectional epidemiological study will be located in three towne (Katowice, Sosnowiec, Gliwice). In each town a representative age-stratified sample of 2000 subjects will undergo questionnaire assessment and serological examination performed by serological test. The project corresponds with analogous population-based studies on COVID-19 in a number of countries and responds to the WHO recommendation in that field.

详细描述

Project is designed as a comprehensive population-based epidemiological study in Upper-Silesian Conurbation (Poland) aiming at:

  1. analysis of available data on incidence and mortality due to COVID-19 and
  2. estimation of the occurrence of viral infection SARS-CoV-2 as revealed by the results of serological test (ELISA: IgM, IgG), with assessment of risk factors.

The project's objectives are: to assess incidence and mortality due COVID-19 according to sex, age and coexisting diseases; to determine the level of potential "underdiagnosis" of the magnitude of COVID-19 mortality using vital statistics data for Upper-Silesian Conurbation; to assess the prevalence of SARS-CoV-2 based on the level of seropositivity in Upper-Silesian Conurbation; to identify host-related and environmental risk factors if the infection. Analysis of existing data will include monthly records on incidence and mortality over the period 01.01.2020-31.12.2020 and comparison of the findings with the monthly records of 2018 and 2019, for the same population. Cross-sectional epidemiological study will be located in three towne (Katowice, Sosnowiec, Gliwice). In each town a representative age-stratified sample of 2000 subjects will undergo questionnaire assessment and serological examination performed by serological test. The project corresponds with analogous population-based studies on COVID-19 in a number of countries and responds to the WHO recommendation in that field.

研究设计

研究类型
Observational
观察模型
Case Crossover
时间视角
Cross Sectional

入排标准

性别
All
接受健康志愿者

入选标准

  • citizens of one of three towns (Katowice, Sosnowiec, Gliwice) with no age limits

排除标准

  • person who is not able to contact laboratory and obtain blood sample.

结局指标

主要结局

Estimation of prevalence of specific anti-SARS-CoV-2 IgM and IgG antibodies in general population.

时间窗: 8 months

Estimation of real prevalence of elevated IgM and IgG COVID antibodies in general population will allow to estimate real number of current and past COVID infection in the population.

次要结局

  • Frequency of asymptomatic course of COVID in individuals with anti-SARS-CoV2 antibodies(8 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Prof. Grzegorz Brożek, MD PhD

Prof. Grzegorz Brożek, MD PhD

Medical University of Silesia

研究点 (1)

Loading locations...

相似试验